MDMA, psilocybin, and ketamine are expected to significantly transform psychiatry, with psilocybin and MDMA likely to be legalized.

“i really believe we're going to see a massive change in the face of psychiatric work with regard to software as we mentioned earlier in in the next few years which is amazing in dealing with trauma and accessing these these callous these granulomatous traumas that people are having a lot of trouble getting to in the daily life”

“i deeply believe that psychedelics like psilocybin um like ketamine and like mdma will transform the face of psychiatry in the next few years thankfully cytocybin and mdma will likely find legalization and removal from class 1 schedules in the next few years and i think this is a great thing for our health as a human population”

“psilocybin and MDMA both of which I've talked about in previous podcasts as they pertain to trauma I'm curious as to what your experiences with this and maybe more importantly what is your optimism around around these two molecules um both of which are really moving quite along a pathway towards a clinical approval a legalization uh for clinical use”

“I see it as among the the the brightest sort of shining hopes for the future and and I think the the data both from decades ago and the the more recent data and the clinical experience and trials and the the firsthand reports like tell us things that are so incredibly powerful and that fit with a lot of what we've thought about and understood about brain biology and about psychology right”

“i think all of this is pointing towards a world in which we're going to see certainly mdma and potentially eventually psilocybin being used as adjuncts to that type of therapy”